In addition, the most recent edition of the Guidelines contains changes to the maximum word/page count for several article types. Authors should note the following technical requirements:
- Manuscript line numbering should begin with the page containing the abstract and key words. Page numbering should begin with the title page.
- Figures submitted with articles should be black and white and should be able to be reproduced with minimal editing or resizing. All text within figures should be legible at the size at which it will be printed. For research articles, figures should be either 3.375 inches wide (1 column) or 7 inches wide (2 columns). For columns (e.g., Brief Report), figures should be 2.25, 4.625, or 7 inches wide.
Finally, note that starting in May 2017, single-subject case reports will not be considered for publication; papers must have an N of at least 3. Space constraints and a backlog of non-research articles awaiting publication prevent us from considering "The Issue Is . . ." manuscripts at this time.
Beginning January 1, 2016, clinical trials that are the subject of manuscripts submitted to AJOT must be registered with https://clinicaltrials.gov/ (or, for non-U.S. researchers, a similar public clinical trials registry). All trials commencing participant recruitment on or after January 1, 2016, should be registered prospectively (i.e., before recruiting participants). Trials that started or finished recruitment before January 1, 2016, but are the subject of manuscripts submitted on or after that date must be retrospectively registered.
The trial registration website address and trial registration number must be included in the final, unmasked manuscript in the Acknowledgments section.
AJOT uses the National Institutes of Health (2014) definition of clinical trial:
A research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.
Refer to the NIH website (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-015.html) for definitions of terms and more information.
Authors may now purchase immediate open access for articles. To do so, please email email@example.com.
Kudos: Get the Word Out About One's Research!
To help AJOT authors publicize their research to colleagues and funders, all authors—corresponding authors as well as contributing authors—are encouraged to participate in a free service called Kudos. Authors can use Kudos to make outreach efforts more effective:
- Open up research to new audiences.
- Track the most effective networks for getting one's work read, discussed, and cited.
- Learn where to focus efforts to make best use of time.
- Improve the metrics by which one's reach is evaluated.
With Kudos, authors can do the following:
- Tell the story behind the research: Explain what the work is about and why it is important in plain language. Researchers can include a personal perspective that shares their experiences and inspirations with potential readers.
- Keep track of all outreach: Kudos links can be shared through any existing social media networks (Twitter, ResearchGate, LinkedIn, etc.); its central dashboard maps any clicks on these links against changes in the number of downloads, altmetrics, and citations.
- Manage all publications in one place: Kudos can be used to explain and share publications from any publisher that uses CrossRef DOIs. Researchers can also add links to related resources that further help explain the research, set it in context, or connect it to more recent activity in the field.
Centralizing outreach efforts and mapping them against meaningful metrics will let researchers make the most of their scarce time and improve understanding of which activities are most effective.
We encourage authors to take advantage of this free service. Questions may be directed to firstname.lastname@example.org.